Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

New drug shows impressive results against lipoprotein(a), a genetic form of cholesterol that affects millions but remains ...

Deciding whether to start hormone therapy during the menopause transition, the life phase that's the bookend to puberty and ...

About a quarter of people risk heart attacks and strokes because they inherited a kind of cholesterol that statin drugs can’t ...

Lepodisiran, a new drug, slashed levels of “stealthy cholesterol”—a hidden heart risk affecting 1 in 5 people—by up to 95% in ...

High levels of a chemical that is believed to be behind sudden and inexplicable heart attacks and strokes could soon have ...

In general, there are two main types of cholesterol: Low-Density Lipoprotein (LDL) and High-Density Lipoprotein (HDL) cholesterol. High levels of LDL, also known as 'bad' cholesterol, can lead to ...

A recent study shows that traditional insulin resistance measures such as HOMA-IR are more predictive of insulin resistance ...

UVA professor Dr. Christopher Kramer explains how a new Eli Lilly drug may cut a significant heart attack risk factor by 95%.

Many Americans are unaware that elevated levels of this particle — known as lipoprotein(a) or Lp(a) — are circulating in their blood. Elevated Lp(a) cannot be modified with lifestyle changes ...

CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein (a), with ...